Dr Judy Chou, CEO, President and Board Member of AltruBio, Inc, explains how agonist antibodies show potential as a novel therapeutic approach in immunological diseases.

Ulcerative colitis (UC) is a chronic gut inflammatory condition affecting the colon in humans. This study uses human samples as well as a mouse model of colitis induced by a chemical, DSS, to ...

A certain vitamin deficiency could trigger autoimmune conditions. Researchers at McGill University in Canada studied mice ...

The phase 2 INVINCIBLE-4 clinical trial is currently underway in patients with localized triple-negative breast cancer.

Mirikizumab, a drug currently approved by the Food and Drug Administration (FDA) for the treatment of ulcerative colitis, ...

But how cardiovascular disease affects sleep has ... after a mouse’s heart attack, immune cells called monocytes flooded its brain. These cells produced large amounts of a protein called tumour ...

Alopecia areata was more likely to develop in patients with inflammatory bowel disease (IBD) who were taking anti–tumor necrosis factor (TNF) therapy at the onset of the condition.

In a recent study published in Nature, researchers examine how sleep impacts inflammation and recovery following a heart ...

Researchers have found a process by which the brain guards against attack by the immune system. In mice with multiple sclerosis, such 'guardian' proteins that train the immune system were drastically ...

Stanford type A aortic dissection (AD) is a degenerative aortic remodeling disease and carries a high mortality rate. It ...

BRIDGEWATER, NJ / ACCESSWIRE / October 30, 2024 / Tharimmune, Inc. (NASDAQ:THAR) ('Tharimmune' or the 'Company'), a clinical-stage biotechnology ...

The Department of Biology hosted Detlef Weigel, director at the Max Planck Institute for Biology Tübingen and member of the ...